NewsBenzingaHC Wainwright & Co.维持对Vir Biotechnology的买入评级，将目标股价上调至22美元 HC Wainwright & Co.维持对Vir Biotechnology的买入评级，将目标股价上调至22美元 Benzinga 2026.10.07 14:21 (GMT+0) Open on Benzinga Other news 21.84% of AST SpaceMobile’s Float Is Betting Against It. Here’s What the Convoy Doesn’t Fix. Despite a 473% Rally Over the Past Year, This Analyst Says Micron Stock Is Still ‘Dirt Cheap’ You Likely Haven’t Heard of Arrow Electronics, But Its Stock Is Red Hot at New All-Time Highs Constellation Lands a 3,590 MW Power Deal With Google. AI’s Quietest Winner May Not Stay Quiet for Long. 'Saudi Arabia launches air safety probe into flydubai incident, sources say'- Reuters Exclusive Barclays Maintains Overweight on Royal Caribbean Group, Lowers Price Target to $337
Constellation Lands a 3,590 MW Power Deal With Google. AI’s Quietest Winner May Not Stay Quiet for Long.
